Welcome to LookChem.com Sign In|Join Free

CAS

  • or

161564-09-6

Post Buying Request

161564-09-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

161564-09-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 161564-09-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,5,6 and 4 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 161564-09:
(8*1)+(7*6)+(6*1)+(5*5)+(4*6)+(3*4)+(2*0)+(1*9)=126
126 % 10 = 6
So 161564-09-6 is a valid CAS Registry Number.

161564-09-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (3R,5R)-1-benzyl-5-(tert-butyldimethylsilanyloxy)-piperidin-3-ol

1.2 Other means of identification

Product number -
Other names (3R,5R)-1-benzyl-5-[(tert-butyldimethylsilyl)oxy]-piperidin-3-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:161564-09-6 SDS

161564-09-6Relevant articles and documents

Substituted pyridine compound and its method and use thereof

-

, (2018/06/21)

The invention relates to a novel substitutive pyridine compound, and a pharmaceutically acceptable salt and a pharmaceutical preparation of the substitutive pyridine compound for regulating the activity of protein kinases and regulating signal responses between cells or in the cells. Meanwhile, the invention further relates to a pharmaceutical composition containing the compound provided by the invention, and a method for treating high proliferative diseases of mammals, especially human with the pharmaceutical composition.

Enantioselective diethylzinc addition to aromatic and aliphatic aldehydes using (3R,5R)-dihydroxypiperidine derivatives catalyst

Roudeau, Rémi,Gomez Pardo, Domingo,Cossy, Janine

, p. 2388 - 2394 (2007/10/03)

A series of chiral (3R,5R)-dihydroxypiperidine derivatives 3a-f were conveniently prepared from trans-4-hydroxy-l-proline and applied to the catalytic enantioselective addition of diethylzinc to benzaldehyde and heptanal. Among them, 3d was found to show

Design and synthesis of conformationally frozen peptide nucleic acid backbone: Chiral piperidine PNA as a hexitol nucleic acid surrogate

Lonkar, Pallavi S.,Kumar, Vaijayanti A.

, p. 2147 - 2149 (2007/10/03)

The design and facile synthesis of novel chiral piperidine PNA from naturally occurring 4-hydroxy-L-proline is reported. The stereospecific ring-expansion reaction to get six-membered piperidine derivative from 5-membered pyrrolidine derivative is exploit

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 161564-09-6